|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 2 of 14 found articles
| Title: |
Breathe, breathe in the air: the anti-CCN2 antibody pamrevlumab (FG-3019) completes a successful phase II clinical trial for idiopathic pulmonary fibrosis |
| Author: |
Leask, Andrew |
| Appeared in: |
Journal of cell communication and signaling |
| Paging: | Volume 13 () nr. 4 pages 441-442 |
| Year: |
2019-12-07 |
| Contents: | |
| Publisher: |
Springer Netherlands, Dordrecht |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 2 of 14 found articles
| << previous | next >> |